Michal Minczuk
@mitogene.bsky.social
190 followers 140 following 13 posts
Prof. at University of Cambridge @mrc-mbu.bsky.social; co-founder of Pretzeltx.com
Posts Media Videos Starter Packs
Reposted by Michal Minczuk
fusionconf.bsky.social
@mitogene.bsky.social we are looking forward to your presentation at #MitoCellFate in Malta!
Please share this with your followers to let them know the Earlybird & Talk submission deadline is fast approaching - Monday 10 November.
Register & Submit here: bit.ly/46TS4Ii
Reposted by Michal Minczuk
lilyfoundation.bsky.social
It’s here – World Mitochondrial Disease Week! 💚

We’re proud to collaborate with other mito charities across the UK to put mito on the map – let's spread the word together!

👉 See how you can get involved:
🔗 thelilyfoundation.org.uk/charity/get-involved/world-mitochondrial-disease-week
Reposted by Michal Minczuk
fusionconf.bsky.social
Don't forget to register and submit your abstract for our #MitoCellFate conference in Malta next year ☀️

📢Check out our wonderful speaker line-up so far!
📅Early-bird & talk deadline: 10 Nov 2025
bit.ly/46xBYVt

#FusionStemCells #FusionAgingResearch
mitogene.bsky.social
Massive congratulations to @lucialugut.bsky.social on receiving the prestigious 2025 CSAR Award! 🎉 Lucia's groundbreaking work in modeling and correcting mtDNA mutations paves the way for innovative future therapies for mitochondrial diseases. @mrc-mbu.bsky.social www.csar.org.uk/student-awar...
Reposted by Michal Minczuk
Reposted by Michal Minczuk
euromit-2026.bsky.social
🎙️ Focus Speakers – Michal Minczuk
@mitogene.bsky.social

👀 Curious to know who will be speaking at #euromit2026 ?
✨ Today, we’re introducing Michal Minczuk who will be taking the stage at the congress.
#euromit2026 #mitochondria #angers @univangers.bsky.social @ua-recherche.bsky.social
Image of Professor Michal Minczuk and his biography. Michal Minczuk will be speaking at Euromit on Wednesday 3 of June 2026 during the Session 5 entiteld "Innovative technologies". Michal Minczuk is a professor of Mitochondrial Genetics in the Department of Clinical Neurosciences at the University of Cambridge, UK. His research is focused on mitochondrial genetics, as well as on the development of innovative genome engineering technologies, to bring future therapies for diseases caused by mitochondrial dysfunction.
mitogene.bsky.social
Last chance to join us for the Meeting on Mechanisms of Mitochondrial DNA Mutation and Repair, June 1 - 5, 2025 | Nashville, Tennessee @faseborg.bsky.social
faseborg.bsky.social
Last call for genetics scientists to save $150 at #MDNASRC 2025 with a can't-miss keynote presentation from Thomas Langer from @mpiage.bsky.social ... Save your seat by May 12: buff.ly/A12895w
Reposted by Michal Minczuk
mitogene.bsky.social
🚨 Join us for the @faseborg.bsky.social
Meeting on Mechanisms of Mitochondrial DNA Mutation and Repair, June 1 - 5, 2025 | Nashville, Tennessee. 📅 Abstract submission & Early Registration close on April 20, 2025! Don't miss out: events.faseb.org/event/mitoch... Please re-post!
Reposted by Michal Minczuk
paulinawanrooij.bsky.social
Hello fellow mitochondriacs! Are you passionate about mtDNA? We now offer a 2-year postdoc opportunity for studies of mtDNA instability and its signaling. Apply by May 18th to join our international team in exotic Umeå. Please share!
www.umu.se/en/work-with...
Postdoctoral fellowship (2 years) to study mitochondrial DNA stability
www.umu.se
Reposted by Michal Minczuk
lilyfoundation.bsky.social
Yesterday we were proud to join the launch of the LifeArc Centre for Rare Mitochondrial Diseases - a major step forward in mito research

We led a workshop on making complex science clear – because involving patients is key to success

#mitochondrialdisease #mitoresearch #patientvoice #raredisease
Reposted by Michal Minczuk
mrcmitocluster.bsky.social
Very full schedule at our #IMGCglasgow workshop last week, delivered by MitoCluster team @robpitceathly.bsky.social, Carlo Viscomi, @mitogene.bsky.social, and @jim-ca.bsky.social. A pleasure to attend, thanks for the invite @mrcmousenetwork.bsky.social & IMGS! 🧬

#mitochondria #MouseModels #ECR
mitogene.bsky.social
🚨 Join us for the @faseborg.bsky.social
Meeting on Mechanisms of Mitochondrial DNA Mutation and Repair, June 1 - 5, 2025 | Nashville, Tennessee. 📅 Abstract submission & Early Registration close on April 20, 2025! Don't miss out: events.faseb.org/event/mitoch... Please re-post!
Reposted by Michal Minczuk
embomolmed.org
Clinically translatable mitochondrial #GeneTherapy in muscle using tandem mtZFN architecture.
By P. Nash, @mitogene.bsky.social & colleagues @mrc-mbu.bsky.social

🗞️ doi.org/10.1038/s443...

Read also related N&V by A. Ghifari & M. Ott 👉 doi.org/10.1038/s443...
mitogene.bsky.social
Great opportunity!
mitocamb.bsky.social
2x CRA posts extended until end of April. So you have another chance to work with #mito disease patients as part of the @lifearc.bsky.social centre for #rare #mito diseases! See links below to apply!
@eastgenomics.bsky.social @camneuro.bsky.social @cuhnhs.bsky.social
mitocamb.bsky.social
📢 We have not 1 but 3 clinical/patient-facing jobs working with #mitoCAMB on the #LifeArc #raredisease centre for #mito diseases.

1x pre/post-doctoral CRA;
1x post-doctoral CRA (with potential to become a 4 year ACL); 1x research coordinator

Join us! Links below.
mitogene.bsky.social
It would not be possible without: Keira Turner, Chris Powell, @lindseyvanhaute.bsky.social Pedro Pinheiro, Felix Bubeck, Ellen Wiedtke, @ryanlab.bsky.social Dirk Grimm @mito-oncogene.bsky.social - Thank you!!
mitogene.bsky.social
Exciting news from Pretzel Therapeutics! We’ve launched a Phase 1 trial for our POLG activator—PX578—targeting rare mitochondrial syndromes with potential for Parkinson’s & Alzheimer’s diseases.
Congratulations to the entire team—proud to be part of this journey!
www.pretzeltx.com/pretzel-ther...
Pretzel Therapeutics Initiates Phase 1 Clinical Study Evaluating PX578, Lead Therapeutic in its Bioenergetics Restoration Franchise » Pretzel Therapeutics
First-in-class approach to targeting mitochondrial DNA polymerase (POLG) with disease modifying potential across mitochondrial DNA depletion syndromes
www.pretzeltx.com